This page is part of the Logica COVID-19 FHIR Profile Library IG (v0.13.0: Drafts Ballot 1) based on FHIR R4. The current version which supercedes this version is 1.0.0. For a full list of available versions, see the Directory of published versions
Summary
Defining URL: | http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-metabolic-condition-value-set |
Version: | 0.13.0 |
Name: | COVID19UnderlyingMetabolicConditionVS |
Title: | COVID-19 metabolic underlying condition reference set |
Status: | Active as of 2021-08-27T17:17:04+00:00 |
Definition: | A set of codes that describe underlying metabolic conditions for COVID19 |
Publisher: | HL7 International - Clinical Information Modeling Initiative |
Copyright: | This value set includes content from SNOMED CT, which is copyright © 2002+ International Health Terminology Standards Development Organisation (IHTSDO), and distributed by agreement between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this agreement |
Source Resource: | XML / JSON / Turtle |
References
http://snomed.info/sct
Code | Display |
267454002 | Acatalasemia (disorder) |
238069004 | Acyl-coenzyme A oxidase deficiency (disorder) |
363732003 | Addison's disease (disorder) |
386584007 | Adrenal cortical hypofunction (disorder) |
237735008 | Adrenal Cushing's syndrome (disorder) |
65389002 | Adrenoleukodystrophy (disorder) |
700463002 | Alpha-methylacyl-CoA racemase deficiency disorder (disorder) |
54954004 | Aspartylglucosaminuria (disorder) |
238068007 | Bifunctional peroxisomal enzyme deficiency (disorder) |
128289001 | Chronic metabolic disorder (disorder) |
7573000 | Classical phenylketonuria (disorder) |
35691006 | Combined deficiency of sialidase AND beta galactosidase (disorder) |
237751000 | Congenital adrenal hyperplasia (disorder) |
419097006 | Danon disease (disorder) |
124302001 | Deficiency of galactokinase (disorder) |
124437004 | Deficiency of glucose-6-phosphatase (disorder) |
124335006 | Deficiency of phosphoglycerate kinase (disorder) |
124675005 | Deficiency of phosphoglycerate mutase (disorder) |
387817006 | Deficiency of phosphorylase b kinase (disorder) |
124329006 | Deficiency of phosphorylase kinase (disorder) |
46635009 | Diabetes mellitus type 1 (disorder) |
44054006 | Diabetes mellitus type 2 (disorder) |
73211009 | Diabetes mellitus (disorder) |
45744005 | Disorder of mineral metabolism (disorder) |
238059005 | Disorder of peroxisomal function (disorder) |
238006008 | Disorder of purine and pyrimidine metabolism (disorder) |
30171000 | Disorder of adrenal gland (disorder) |
73132005 | Disorder of parathyroid gland (disorder) |
399244003 | Disorder of pituitary gland (disorder) |
190680002 | Disorders of amino acid transport and metabolism (disorder) |
16652001 | Fabry's disease (disorder) |
79935000 | Farber's lipogranulomatosis (disorder) |
717276003 | Folinic acid responsive seizure syndrome (disorder) |
20052008 | Fructose-1,6-bisphosphate aldolase B deficiency (disorder) |
28183005 | Fructose-biphosphatase deficiency (disorder) |
190745006 | Galactosemia (disorder) |
192782005 | Galactosylceramide beta-galactosidase deficiency (disorder) |
190794006 | Glucosylceramide beta-glucosidase deficiency (disorder) |
235908005 | Glycogen storage disease type IX (disorder) |
41527003 | Glycogen storage disease type VIII (disorder) |
37666005 | Glycogen storage disease type X (disorder) |
717821004 | Glycogen storage disease with severe cardiomyopathy due to glycogenin deficiency (disorder) |
7265005 | Glycogen storage disease, type I (disorder) |
274864009 | Glycogen storage disease, type II (disorder) |
66937008 | Glycogen storage disease, type III (disorder) |
11179002 | Glycogen storage disease, type IV (disorder) |
55912009 | Glycogen storage disease, type V (disorder) |
29291001 | Glycogen storage disease, type VI (disorder) |
89597008 | Glycogen storage disease, type VII (disorder) |
237964009 | Glycogen synthase deficiency (disorder) |
61598006 | Glycogenosis with glucoaminophosphaturia (disorder) |
238025006 | GM1 gangliosidosis (disorder) |
353295004 | Graves' disease (disorder) |
21983002 | Hashimoto thyroiditis (disorder) |
111578003 | Hereditary nonspherocytic hemolytic anemia due to aldolase A deficiency (disorder) |
66999008 | Hyperparathyroidism (disorder) |
10649000 | Hyperpituitarism (disorder) |
34486009 | Hyperthyroidism (disorder) |
36976004 | Hypoparathyroidism (disorder) |
74728003 | Hypopituitarism (disorder) |
40930008 | Hypothyroidism (disorder) |
70199000 | I-cell disease (disorder) |
86095007 | Inborn error of metabolism (disorder) |
238062008 | Infantile Refsum's disease (disorder) |
18756002 | Juvenile GM1 gangliosidosis (disorder) |
65524005 | Mannosidosis (disorder) |
27718001 | Maple syrup urine disease (disorder) |
69463008 | Maroteaux-Lamy syndrome (disorder) |
237602007 | Metabolic syndrome X (disorder) |
396338004 | Metachromatic leucodystrophy (disorder) |
725296006 | Mucolipidosis type IV (disorder) |
75610003 | Mucopolysaccharidosis type I (disorder) |
65327002 | Mucopolysaccharidosis type I-H (disorder) |
26745009 | Mucopolysaccharidosis type I-H/S (disorder) |
70737009 | Mucopolysaccharidosis type II (disorder) |
73123008 | Mucopolysaccharidosis type I-S (disorder) |
43916004 | Mucopolysaccharidosis type VII (disorder) |
378007 | Morquio syndrome (disorder) |
238061001 | Neonatal adrenoleucodystrophy (disorder) |
783717008 | Phosphoglucomutase 1-related congenital disorder of glycosylation (disorder) |
5335002 | Phosphoenolpyruvate carboxykinase deficiency (disorder) |
25362006 | Phytanic acid storage disease (disorder) |
65520001 | Primary hyperoxaluria, type I (disorder) |
65764006 | Pseudo-Hurler polydystrophy (disorder) |
734434007 | Pyridoxine-dependent epilepsy (disorder) |
46683007 | Pyruvate dehydrogenase complex deficiency (disorder) |
23849003 | Sandhoff disease (disorder) |
88393000 | Sanfilippo syndrome (disorder) |
38795005 | Sialidosis (disorder) |
58459009 | Sphingomyelin/cholesterol lipidosis (disorder) |
34420000 | Storage disease (disorder) |
367368009 | Sulfite oxidase deficiency (disorder) |
111385000 | Tay-Sachs disease (disorder) |
264580006 | Thyroid dysfunction (disorder) |
8849004 | Uridine diphosphate glucose-4-epimerase deficiency (disorder) |
88469006 | Zellweger syndrome (disorder) |
This value set contains 96 concepts
Expansion based on SNOMED CT United States edition 01-Mar 2021
All codes from system http://snomed.info/sct
Code | Display | Definition |
267454002 | Acatalasemia | |
238069004 | Acyl-CoA oxidase deficiency | |
363732003 | Addison's disease | |
386584007 | Adrenal cortical hypofunction (disorder) | |
237735008 | Adrenal Cushing's syndrome | |
65389002 | Adrenoleukodystrophy | |
700463002 | Alpha-methylacyl-CoA racemase deficiency disorder | |
54954004 | Aspartylglucosaminuria | |
238068007 | Bifunctional peroxisomal enzyme deficiency | |
128289001 | Chronic metabolic disease | |
7573000 | Classical phenylketonuria | |
35691006 | Combined deficiency of sialidase AND beta galactosidase | |
237751000 | Congenital adrenal hyperplasia | |
419097006 | Danon disease (disorder) | |
124302001 | Deficiency of galactokinase | |
124437004 | Deficiency of glucose-6-phosphatase | |
124335006 | Deficiency of phosphoglycerate kinase | |
124675005 | Deficiency of phosphoglyceromutase | |
387817006 | Deficiency of phosphorylase b kinase | |
124329006 | Deficiency of dephosphophosphorylase kinase | |
46635009 | Diabetes mellitus type I | |
44054006 | Diabetes mellitus type II | |
73211009 | Diabetes mellitus | |
45744005 | Disorder of mineral metabolism | |
238059005 | Disorder of peroxisomal function | |
238006008 | Disorder of purine and pyrimidine metabolism | |
30171000 | Disorder of adrenal gland | |
73132005 | Disorder of parathyroid glands | |
399244003 | Pituitary disease | |
190680002 | Disorders of amino acid transport and metabolism | |
16652001 | Fabry's disease | |
79935000 | Farber's lipogranulomatosis | |
717276003 | Folinic acid responsive seizure syndrome (disorder) | |
20052008 | Hereditary fructosuria | |
28183005 | Fructose-biphosphatase deficiency | |
190745006 | Galactosemia | |
192782005 | Galactosylceramide beta-galactosidase deficiency | |
190794006 | Gaucher's disease | |
235908005 | Glycogen phosphorylase kinase deficiency | |
41527003 | Glycogen storage disease type VIII | |
37666005 | Glycogen storage disease type X | |
717821004 | Glycogen storage disease with severe cardiomyopathy due to glycogenin deficiency (disorder) | |
7265005 | Glycogen storage disease, type I | |
274864009 | Glycogen heart disease | |
66937008 | Glycogen storage disease, type III | |
11179002 | Glycogen storage disease, type IV | |
55912009 | Glycogen storage disease, type V | |
29291001 | Glycogen storage disease, type VI | |
89597008 | Glycogen storage disease, type VII | |
237964009 | Glycogen synthase deficiency | |
61598006 | Glycogenosis with glucoaminophosphaturia | |
238025006 | GM1 gangliosidosis | |
353295004 | Graves' disease | |
21983002 | Hashimoto thyroiditis | |
111578003 | Fructose 1,6-biphosphate aldolase A deficiency | |
66999008 | Hyperparathyroidism | |
10649000 | Hyperpituitarism | |
34486009 | Hyperthyroidism | |
36976004 | Hypoparathyroidism | |
74728003 | Hypopituitarism | |
40930008 | Hypothyroidism | |
70199000 | I-cell disease | |
86095007 | Inborn error of metabolism | |
238062008 | Infantile Refsum's disease | |
18756002 | GM1 Gangliosidosis type II | |
65524005 | Mannosidosis | |
27718001 | Maple syrup urine disease | |
69463008 | Maroteaux-Lamy syndrome | |
237602007 | Metabolic syndrome X | |
396338004 | Metachromatic leucodystrophy (disorder) | |
725296006 | Mucolipidosis type IV (disorder) | |
75610003 | Mucopolysaccharidosis, MPS-I | |
65327002 | Mucopolysaccharidosis, MPS-I-H | |
26745009 | Mucopolysaccharidosis, MPS-I-H/S | |
70737009 | Mucopolysaccharidosis, MPS-II | |
73123008 | Mucopolysaccharidosis, MPS-I-S | |
43916004 | Mucopolysaccharidosis, MPS-VII | |
378007 | Morquio syndrome | |
238061001 | Neonatal adrenoleucodystrophy | |
783717008 | PGM1-related congenital disorder of glycosylation | |
5335002 | Phosphoenolpyruvate carboxykinase (GTP) deficiency | |
25362006 | Phytanic acid storage disease | |
65520001 | Primary hyperoxaluria, type I | |
65764006 | Pseudo-Hurler polydystrophy | |
734434007 | Pyridoxine-dependent epilepsy (disorder) | |
46683007 | Pyruvate dehydrogenase complex deficiency | |
23849003 | Sandhoff disease | |
88393000 | Sanfilippo syndrome | |
38795005 | Sialidosis | |
58459009 | Sphingomyelin/cholesterol lipidosis | |
34420000 | Storage disease | |
367368009 | Sulfite oxidase deficiency | |
111385000 | Tay-Sachs disease | |
264580006 | Thyroid dysfunction | |
8849004 | UDPglucose-4-epimerase deficiency | |
88469006 | Zellweger syndrome |
Explanation of the columns that may appear on this page:
Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
Source | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance) |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |